133 related articles for article (PubMed ID: 29353154)
1. CD41 immune staining of micromegakaryocytes improves the diagnosis of myelodysplastic syndrome and differentiation from pancytopenia.
Huang J; Wang Z; Huang L; Zheng M
Leuk Res; 2018 Mar; 66():15-19. PubMed ID: 29353154
[TBL] [Abstract][Full Text] [Related]
2. [An immunohistochemical study on megakaryocytes in patients with myelodysplastic syndromes].
Liu SQ; Liu XF; Song SJ
Zhonghua Bing Li Xue Za Zhi; 1994 Oct; 23(5):288-90. PubMed ID: 7874762
[TBL] [Abstract][Full Text] [Related]
3. [Comparative study on bone marrow megakaryocytes in children with thrombocytopenic purpura, aplastic anemia and myelodysplastic syndrome].
Hu T; Shi XD; Feng YL; Liu R; Li JH; Chen J; Wang TY
Zhonghua Er Ke Za Zhi; 2005 Mar; 43(3):183-7. PubMed ID: 15833188
[TBL] [Abstract][Full Text] [Related]
4. Comparative study of myelodysplastic syndromes and normal bone marrow biopsies with conventional staining and immunocytochemistry.
Das R; Hayer J; Dey P; Garewal G
Anal Quant Cytol Histol; 2005 Jun; 27(3):152-6. PubMed ID: 16121636
[TBL] [Abstract][Full Text] [Related]
5. Megakaryocytopoiesis and apoptosis in patients with myelodysplastic syndromes.
Li X; Pu Q
Leuk Lymphoma; 2005 Mar; 46(3):387-91. PubMed ID: 15621828
[TBL] [Abstract][Full Text] [Related]
6. [Study on bone marrow megakaryocytes in children patients with myelodysplastic syndrome].
Shi XD; Hu T; Feng YL; Liu R; Li JH; Wang TY; Chen J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Feb; 12(1):74-8. PubMed ID: 14989774
[TBL] [Abstract][Full Text] [Related]
7. Atypical micromegakaryocytes, promegakaryoblasts and megakaryoblasts: a critical evaluation by immunohistochemistry, cytochemistry and morphometry of bone marrow trephines in chronic myeloid leukemia and myelodysplastic syndromes.
Thiele J; Titius BR; Kopsidis C; Fischer R
Virchows Arch B Cell Pathol Incl Mol Pathol; 1992; 62(5):275-82. PubMed ID: 1279889
[TBL] [Abstract][Full Text] [Related]
8. [A study on micromegakaryocyte in children with idiopathic thrombocytopenic purpura].
Shi XD; Hu T; Feng YL; Liu R; Li JH; Chen J; Wang TY
Zhonghua Er Ke Za Zhi; 2004 Mar; 42(3):192-5. PubMed ID: 15144713
[TBL] [Abstract][Full Text] [Related]
9. A megakaryocyte analysis of the bone marrow in patients with myelodysplastic syndrome, myeloproliferative disorder and allied disorders.
Ohshima K; Kikuchi M; Takeshita M
J Pathol; 1995 Oct; 177(2):181-9. PubMed ID: 7490685
[TBL] [Abstract][Full Text] [Related]
10. Dysmegakaryopoiesis in myelodysplastic syndromes (MDS): an immunomorphometric study of bone marrow trephine biopsy specimens.
Thiele J; Quitmann H; Wagner S; Fischer R
J Clin Pathol; 1991 Apr; 44(4):300-5. PubMed ID: 2030148
[TBL] [Abstract][Full Text] [Related]
11. Comparative study of immunocytochemical staining versus Giemsa stain for detecting dysmegakaryopoiesis in myelodysplastic syndromes (MDS).
Kawaguchi M; Nehashi Y; Aizawa S; Toyama K
Eur J Haematol; 1990 Feb; 44(2):89-94. PubMed ID: 2318299
[TBL] [Abstract][Full Text] [Related]
12. [Bone marrow histological changes in myelodysplastic syndrome and its clinical significance].
Liu XF; Wang BM; Yi FH
Zhonghua Nei Ke Za Zhi; 1991 Nov; 30(11):675-7, 729. PubMed ID: 1815870
[TBL] [Abstract][Full Text] [Related]
13. Megakaryocytic ploidy in myelodysplastic syndromes.
Kobayashi Y; Ozawa M; Maruo N; Kondo M
Leuk Lymphoma; 1993 Jan; 9(1-2):55-61. PubMed ID: 8477202
[TBL] [Abstract][Full Text] [Related]
14. Relationship between morphological classification of the degree of maturation and the ploidy of micromegakaryocytes in myelodysplastic syndrome patients.
Kobayashi Y; Uoshima N; Kimura S; Tanaka K; Wada K; Ozawa M; Maruo N; Kondo M
Int J Hematol; 1995 Apr; 61(3):117-22. PubMed ID: 7599323
[TBL] [Abstract][Full Text] [Related]
15. Myelodysplastic syndrome: diagnostic implications of cytochemical and immunocytochemical studies.
Seo IS; Li CY; Yam LT
Mayo Clin Proc; 1993 Jan; 68(1):47-53. PubMed ID: 7678045
[TBL] [Abstract][Full Text] [Related]
16. Bone marrow immunophenotyping by flow cytometry in refractory cytopenia of childhood.
Aalbers AM; van den Heuvel-Eibrink MM; Baumann I; Dworzak M; Hasle H; Locatelli F; De Moerloose B; Schmugge M; Mejstrikova E; Nováková M; Zecca M; Zwaan CM; Te Marvelde JG; Langerak AW; van Dongen JJ; Pieters R; Niemeyer CM; van der Velden VH
Haematologica; 2015 Mar; 100(3):315-23. PubMed ID: 25425683
[TBL] [Abstract][Full Text] [Related]
17. Are micromegakaryocytes specific for refractory cytopenia of childhood (RCC)? A study of 38 pediatric patients with thrombocytopenia unrelated to RCC.
Aqil B; Punia JN; Curry CV; Marcogliese AN; Elghetany MT
Leuk Res; 2016 Aug; 47():84-7. PubMed ID: 27285854
[TBL] [Abstract][Full Text] [Related]
18. [Clinical significance of micromegakaryocytes in de novo AML].
Kobayashi S; Seki K; Katayama N; Akiba C; Yamamoto T; Sakai K; Yamaguchi M; Maruta A; Noguchi T; Ogawa K
Rinsho Ketsueki; 1993 Mar; 34(3):313-20. PubMed ID: 8479083
[TBL] [Abstract][Full Text] [Related]
19. [Study on bone marrow megakaryocytes in children patients with idiopathic thrombocytopenic purpura].
Hu T; Shi XD; Feng YL; Liu R; Li JH; Wang TY; Chen J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Aug; 12(4):480-3. PubMed ID: 15363136
[TBL] [Abstract][Full Text] [Related]
20. Characterization of myelodysplastic syndrome and aplastic anemia by immunostaining of p53 and hemoglobin F and karyotype analysis: differential diagnosis between refractory anemia and aplastic anemia.
Iwasaki T; Murakami M; Sugisaki C; Sobue S; Ohashi H; Asano H; Suzuki M; Nakamura S; Ito M; Murate T
Pathol Int; 2008 Jun; 58(6):353-60. PubMed ID: 18477214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
